Luke Corning

Luke Corning

Director/Board Member presso POSEIDA THERAPEUTICS, INC.

Patrimonio netto: 125 367 $ in data 31/03/2024

41 anni
Health Technology
Consumer Services
Finance

Provenienza dei contatti di primo grado di Luke Corning

EntitàTipo di entitàSettore Industriale
Public Company Biotechnology 26
6
Private Company Investment Managers 6
Public Company Biotechnology 3

Grafico delle società connesse in secondo grado

Relazione in diverse aziende

Società connesse a Luke Corning tramite i suoi contatti personali

SocietàSettorePersone collegatePosizione principale
AMGEN INC. Pharmaceuticals: Major

Kristin Yarema

Jeff Knight

Corporate Officer/Principal

Corporate Officer/Principal

Medical Specialties

Marcea Lloyd

Mark Gergen

Corporate Officer/Principal

Corporate Officer/Principal

PFIZER, INC. Pharmaceuticals: Major

Matthew A. Spear

Catherine Mackey

Charles Baum

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Investment Managers

Ravi Govindram Mehta

Daniel Bae

Analyst-Equity

Corporate Officer/Principal

SEQUENOM, INC. Medical Specialties

Catherine Mackey

Marcy Graham

Director/Board Member

Investor Relations Contact

ARRAY TECHNOLOGIES, INC. Pharmaceuticals: Major

Charles Baum

Director/Board Member

HALOZYME THERAPEUTICS, INC. Biotechnology

Harry Leonhardt

Mark Gergen

Jeff Knight

Compliance Officer

Chief Operating Officer

Corporate Officer/Principal

Medical Specialties

Harry Leonhardt

Marcy Graham

General Counsel

Public Communications Contact

ATYR PHARMA, INC. Pharmaceuticals: Major

Marcy Graham

Danielle Campbell

Investor Relations Contact

Human Resources Officer

Biotechnology

Eric Ostertag

Chief Executive Officer

Pharmaceuticals: Major

Eric Ostertag

Director/Board Member

Biotechnology

Eric Ostertag

Chief Executive Officer

Investment Managers

Paul Bard

Director of Research - Equity

Dartmouth College College/University

Chris Pedrick

Undergraduate Degree

College/University

Ravi Govindram Mehta

Undergraduate Degree

Stanford University College/University

Matthew A. Spear

Kristin Yarema

Doctorate Degree

Undergraduate Degree

University of Pennsylvania College/University

Eric Ostertag

Devon J. Shedlock

Doctorate Degree

Doctorate Degree

Financial Conglomerates

David Duback

Daniel Bae

Corporate Officer/Principal

Corporate Officer/Principal

College/University

Harry Leonhardt

Loren Wagner

Graduate Degree

Graduate Degree

MIRATI THERAPEUTICS Biotechnology

Mark Gergen

Marcy Graham

Charles Baum

Chief Operating Officer

Investor Relations Contact

Chief Executive Officer

The Johns Hopkins University College/University

David Hirsch

Matthew A. Spear

Undergraduate Degree

Undergraduate Degree

Tufts University College/University

Kerry Ingalls

Graduate Degree

United States Naval Academy College/University

Kerry Ingalls

Undergraduate Degree

New York University College/University

Paul Bard

Undergraduate Degree

University of Wisconsin College/University

Eric Ostertag

David Duback

Undergraduate Degree

Undergraduate Degree

University of San Diego College/University

John Schmid

Johanna Mylet

Masters Business Admin

Undergraduate Degree

Wesleyan University College/University

John Schmid

Undergraduate Degree

Miscellaneous Commercial Services

Harry Leonhardt

Catherine Mackey

Director/Board Member

Director/Board Member

Investment Managers

Ravi Govindram Mehta

Corporate Officer/Principal

Financial Conglomerates

John Schmid

President

Miscellaneous Commercial Services

Kerry Ingalls

Director/Board Member

Investment Managers

Chris Pedrick

Trading-Equity

Biotechnology

Eric Ostertag

Founder

Medical/Nursing Services

Cynthia Collins

Kristin Yarema

Director/Board Member

Director/Board Member

Financial Conglomerates

Ravi Govindram Mehta

Corporate Officer/Principal

Harvard Business School College/University

Ravi Govindram Mehta

Masters Business Admin

Washington University School of Medicine College/University

Charles Baum

Doctorate Degree

VOYAGER THERAPEUTICS, INC. Biotechnology

Catherine Mackey

Director/Board Member

IDEAYA BIOSCIENCES, INC. Pharmaceuticals: Major

Catherine Mackey

Director/Board Member

University of Illinois At Urbana–Champaign College/University

Cynthia Collins

Sean Murphy

Undergraduate Degree

Graduate Degree

DERMTECH, INC. Medical Specialties

Cynthia Collins

Patrick Johnson

Director/Board Member

Chief Tech/Sci/R&D Officer

Investment Managers

Ravi Govindram Mehta

Private Equity Investor

AADI BIOSCIENCE, INC. Biotechnology

Marcy Graham

Investor Relations Contact

Statistiche

Distribuzione geografica

Stati Uniti 48
Regno Unito 2

Settori

Health Technology 21
Consumer Services 16
Finance 10
Commercial Services 4
Health Services 2

Posizioni

Director/Board Member 119
Corporate Officer/Principal 69
Independent Dir/Board Member 37
Undergraduate Degree 31
Chief Executive Officer 14